Corvus Pharmaceuticals, Inc. (FRA:C17)
Germany flag Germany · Delayed Price · Currency is EUR
6.42
+0.23 (3.72%)
At close: Jan 2, 2026

Corvus Pharmaceuticals Market Cap

Corvus Pharmaceuticals has a market cap or net worth of €435.95 million as of January 9, 2026. Its market cap has increased by 55.03% in one year.

Market Cap
435.95M
Enterprise Value
380.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.42

Market Cap Chart

Since March 24, 2016, Corvus Pharmaceuticals's market cap has increased from 260.30M to 435.95M, an increase of 67.48%. That is a compound annual growth rate of 5.40%.

History

DateMarket Cap% Change
Jan 9, 2026435.95M-10.99%
Dec 31, 2025489.77M47.50%
Dec 31, 2024332.05M325.26%
Dec 29, 202378.08M110.89%
Dec 30, 202237.03M-62.46%
Dec 31, 202198.64M20.78%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Mar 24, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition